Key Points

  • Daktronics currently combines a Zacks Rank of #2 (Buy) with an A grade for value, placing the stock among companies attracting attention from fundamental investors.
  • Its 19.28 price-to-earnings ratio remains below the industry average of 27.65, while its 1.12 price-to-sales ratio compares favorably with an industry average of 1.92.
  • A PEG ratio of 0.64 also indicates that the market valuation may not fully reflect expected earnings growth, although investors still need to consider execution and future growth risks.
hero

Daktronics Trades at a Discount to Its Industry

Daktronics is drawing renewed attention from value-focused investors as several traditional valuation measures point to a discount relative to its industry. The company currently trades at a P/E ratio of 19.28, compared with an industry average of 27.65. That gap suggests investors are paying considerably less for each dollar of earnings than they are for comparable companies.

The historical range provides additional context. During the past year, Daktronics’ forward P/E has reached as high as 20.96 and fallen as low as 11.24, with a median of 14.60. The current valuation therefore sits above its recent median, meaning the stock is not necessarily cheap by its own historical standards. However, the discount to the broader industry becomes more meaningful if earnings growth continues to exceed expectations.

Growth-Adjusted Valuation Adds to the Appeal

The PEG ratio provides another perspective because it incorporates expected earnings growth alongside the traditional P/E multiple. Daktronics has a PEG ratio of 0.64, compared with 1.08 for its industry. A lower figure can indicate that investors are paying less for anticipated earnings growth, potentially strengthening the stock’s appeal for investors seeking a balance between valuation and expansion.

Daktronics’ PEG ratio has ranged between 0.37 and 0.70 over the past year, with a median of 0.49. The current reading is therefore elevated relative to its recent historical midpoint, but it remains below the industry benchmark. This distinction is important because a valuation can appear attractive compared with competitors while still reflecting increased optimism about future performance.

Sales and Cash Flow Metrics Support the Value Case

Revenue-based valuation also favors Daktronics. Its price-to-sales ratio stands at 1.12, substantially below the industry average of 1.92. Because sales generally provide a less direct target for accounting adjustments than earnings, the metric can offer investors another way to evaluate whether a company’s market capitalization is justified by the scale of its business.

The company’s price-to-cash-flow ratio is similarly below its industry benchmark, at 35.81 versus 59.56. However, this measure is above Daktronics’ one-year median of 27.56, suggesting that the stock has become more expensive on a cash-flow basis than it was during much of the previous year.

The broader investment case will ultimately depend on whether Daktronics can convert its earnings outlook into sustained operating performance. Its favorable valuation metrics provide a margin of attraction, while the #2 Zacks Rank indicates positive expectations around earnings revisions. Investors should therefore monitor earnings growth, cash generation and changes in valuation multiples. If operating momentum persists without a comparable expansion in the share price, the stock could retain appeal for investors searching for reasonably valued growth opportunities.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Could Tesla’s China Sales Rebound Sustain Its Stock Rally Despite Margin Pressures?
    • Lior mor
    • •
    • 7 Min Read
    • •
    • ago 1 day

    SKN | Could Tesla’s China Sales Rebound Sustain Its Stock Rally Despite Margin Pressures? SKN | Could Tesla’s China Sales Rebound Sustain Its Stock Rally Despite Margin Pressures?

    Tesla shares advanced on October 9 after new figures showed continued growth in sales of vehicles produced at the company’s

    • ago 1 day
    • •
    • 7 Min Read

    Tesla shares advanced on October 9 after new figures showed continued growth in sales of vehicles produced at the company’s

    SKN | Indian Stocks Set to Rebound After Selloff as Rising Oil Prices Threaten Gains
    • Lior mor
    • •
    • 6 Min Read
    • •
    • ago 2 days

    SKN | Indian Stocks Set to Rebound After Selloff as Rising Oil Prices Threaten Gains SKN | Indian Stocks Set to Rebound After Selloff as Rising Oil Prices Threaten Gains

    Indian shares were poised to recover at the open on Friday after a sharp selloff pushed benchmark indexes to multi-year

    • ago 2 days
    • •
    • 6 Min Read

    Indian shares were poised to recover at the open on Friday after a sharp selloff pushed benchmark indexes to multi-year

    SKN | Viatris will acquire Pacira BioSciences for $1.65 billion, expanding its presence in non-opioid pain treatments.
    • omer bar
    • •
    • 6 Min Read
    • •
    • ago 2 days

    SKN | Viatris will acquire Pacira BioSciences for $1.65 billion, expanding its presence in non-opioid pain treatments. SKN | Viatris will acquire Pacira BioSciences for $1.65 billion, expanding its presence in non-opioid pain treatments.

    Viatris has agreed to acquire Pacira BioSciences for $1.65 billion, expanding its portfolio of branded medicines as pharmaceutical companies seek

    • ago 2 days
    • •
    • 6 Min Read

    Viatris has agreed to acquire Pacira BioSciences for $1.65 billion, expanding its portfolio of branded medicines as pharmaceutical companies seek

    SKN | RTX’s Raytheon Wins Missile Defense Contract Worth Up to $6.3 Billion
    • Ronny Mor
    • •
    • 6 Min Read
    • •
    • ago 2 days

    SKN | RTX’s Raytheon Wins Missile Defense Contract Worth Up to $6.3 Billion SKN | RTX’s Raytheon Wins Missile Defense Contract Worth Up to $6.3 Billion

    RTX’s Raytheon has secured a U.S. military contract valued at up to $6.3 billion, adding another major award to a

    • ago 2 days
    • •
    • 6 Min Read

    RTX’s Raytheon has secured a U.S. military contract valued at up to $6.3 billion, adding another major award to a